Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Drug Substance

We provide our clients with a full offering of drug substance development, scale up and manufacture, along with comprehensive support services. Our skilled scientists are highly experienced in the development of bespoke and innovative solutions for technically difficult challenges. We pride ourselves on offering clients a better deal, producing economical processes for high purity drug substances that can be scaled up for further manufacture.

View the Drug Substance Equipment and Capabilities list

View the QC & Molecule Development Equipment and Capabilities List